Unraveling the potential of microalgae for the biomanufacturing of therapeuric proteins Company Profile ALGENICS is a biotechnology company focused on innovative uses of microalgae to produce recombinant biotherapeutics. Our platform of synthetic biology AlgebiosysTM encompasses tools and technologies to efficiently generate stable strain of high-producing microalgal cells. This proprietary and patented platform allows the biomanufacturing of a broad range of therapeutics in our PTA cell line, including glycoproteins and cytotoxics. ALGENICS was founded in 2008 as a spin-off from IFREMER (The French Research Institute for Exploitation of the Sea) and opened in 2009 its own facility in Nantes (France).
| Website | http://www.algenics.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2008 |
| Technologies |
HTML
,
G Suite
,
Bootstrap
+5 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Microalgae, Biotechnology, Biotherapeutics, Biomanufacturing, Therapeutic Proteins, Recombinant Proteins, Protein Production, Algae Biotechnology, Synthetic Biology, Microalgae Cultivation, Sustainable Biomanufacturing, Pharmaceutical Manufacturing, Advanced Biomanufacturing |
Looking for a particular Algenics employee's phone or email?
Algenics Questions
1 people are employed at Algenics.
Related Companies
